| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria
2 Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Correspondence
Christian W. Mandl
christian.mandl{at}univie.ac.at
The flavivirus tick-borne encephaltis virus (TBEV) was established as a vector system for heterologous gene expression. The variable region of the genomic 3' non-coding region was replaced by an expression cassette consisting of the reporter gene enhanced green fluorescent protein (EGFP) under the translational control of an internal ribosomal entry site element, both in the context of an infectious virus genome and of a replicon lacking the genes of the surface proteins prM/M and E. The expression level and the stability of expression were measured by fluorescence-activated cell-sorting analysis and compared to an established alphavirus replicon vector derived from Venezuelan equine encephaltis virus (VEEV), expressing EGFP under the control of its natural subgenomic promoter. On the first day, the alphavirus replicon exhibited an approximately 180-fold higher expression level than the flavivirus replicon, but this difference decreased to about 20- and 10-fold on days 2 and 3, respectively. Four to six days post-transfection, foreign gene expression by the VEEV replicon vanished almost completely, due to extensive cell killing. In contrast, in the case of the TBEV replicon, the percentage of positive cells and the amount of EGFP expression exhibited only a moderate decline over a time period of almost 4 weeks. The infectious TBEV vector expressed less EGFP than the TBEV replicon at all times. Significant expression from the infectious vector was maintained for four cell-culture passages. The results indicate that the VEEV vector is superior with respect to achieving high expression levels, but the TBEV system may be advantageous for applications that require a moderate, but more enduring, gene expression.
This article has been cited by other articles:
|
|
 |
|
  C. Taucher, A. Berger, and C. W. Mandl A trans-Complementing Recombination Trap Demonstrates a Low Propensity of Flaviviruses for Intermolecular Recombination J. Virol., January 1, 2010; 84(1): 599 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Orlinger, R. M. Kofler, F. X. Heinz, V. M. Hoenninger, and C. W. Mandl Selection and Analysis of Mutations in an Encephalomyocarditis Virus Internal Ribosome Entry Site That Improve the Efficiency of a Bicistronic Flavivirus Construct J. Virol., November 15, 2007; 81(22): 12619 - 12629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Orlinger, V. M. Hoenninger, R. M. Kofler, and C. W. Mandl Construction and Mutagenesis of an Artificial Bicistronic Tick-Borne Encephalitis Virus Genome Reveals an Essential Function of the Second Transmembrane Region of Protein E in Flavivirus Assembly J. Virol., December 15, 2006; 80(24): 12197 - 12208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bukreyev, M. H. Skiadopoulos, B. R. Murphy, and P. L. Collins Nonsegmented Negative-Strand Viruses as Vaccine Vectors J. Virol., November 1, 2006; 80(21): 10293 - 10306. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Puig-Basagoiti, T. S. Deas, P. Ren, M. Tilgner, D. M. Ferguson, and P.-Y. Shi High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4980 - 4988. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
